Review
Copyright ©The Author(s) 2021.
World J Clin Cases. May 6, 2021; 9(13): 2951-2968
Published online May 6, 2021. doi: 10.12998/wjcc.v9.i13.2951
Table 2 Clinical complications and outcomes of cirrhotic patients infected with SARS-CoV-2
Reference
Patient number (n)
COVID-19 severity
COVID-19 complications
Mortality
Qi et al[33]21N/AICU: 23.8%23.8%
MV: 14.3%
Shock: 14.3%
ARDS: 28.6%
RRT: 9.5%
ECMO: 9.5%
Liu et al[32]17Mild1: 64.7%ICU: 17.6%17.6%
Severe1: 35.3%MV: 11.8%
Shock: 11.8%
ARDS: 29.4%
Iavarone[31] et al50N/AICU: 4%34%
MV: 4%
Shock: 8%
ARDS: 52%
Sarin et al[14]43Severe2: 18.6%ICU: 25.6%16.3%
MV: 23.2%
Shock: 14%
Moon et al[19]103N/AICU: 23.3%39.8%
MV: 17.5%
RRT: 4.9%
Lee et al[22]14N/AICU: 35.7%MV: 21.4%28.6%
RRT: 7.1%
Shock: 28.6%
ARDS: 35.7%
Bajaj et al[23]37N/AICU: 43%30%
MV: 38%
Shock: 30%
RRT: 19%
Kim et al[21]227N/A Death, hospitalization, oxygen support, ICU, vasopressor support, or MV: 70.5% 25.1%
Shalimar et al[30]26Mild3: 57.7%N/A42.3%
Moderate3: 7.7%
Severe3: 34.6%
Marjot et al[18]386N/AICU: 28%32%
MV: 18.4%
RRT: 5.4%
Jeon et al[28]67N/AICU: 3%9%
Shock: 6%
RRT: 1.5%